Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 7850708, 6 pages
https://doi.org/10.1155/2017/7850708
Review Article

Association between the TACC3 rs798766 Polymorphism and Risk of Urinary Bladder Cancer: A Synthesis Based on Current Evidence

1Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China
2Institut Curie, PSL Research University, CNRS, UMR 144, 75005 Paris, France
3Université Paris Sud, Université Paris-Saclay, CNRS, UMR 144, 91405 Orsay, France
4Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China

Correspondence should be addressed to Xiang-Yu Meng; moc.361@uhw_yxgnem

Received 7 February 2017; Accepted 30 April 2017; Published 5 June 2017

Academic Editor: Paola Gazzaniga

Copyright © 2017 Xiang-Yu Meng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Xiang-Yu Meng, Ming-Jun Shi, Jia-Feng Chen, Yi Liao, Bang-Wang Hu, and Ahmed Hireche, “Association between the TACC3 rs798766 Polymorphism and Risk of Urinary Bladder Cancer: A Synthesis Based on Current Evidence,” Disease Markers, vol. 2017, Article ID 7850708, 6 pages, 2017. https://doi.org/10.1155/2017/7850708.